Cytokine release syndrome during ipilimumab and nivolumab therapy for renal-cell carcinoma successfully treated with tocilizumab: A case report. (PubMed, Int Cancer Conf J) - Sep 25, 2026 - "Cytokine release syndrome is a life-threatening complication characterized by progressive organ toxicity that requires prompt diagnosis and treatment. When corticosteroid therapy is insufficient, tocilizumab, an anti-interleukin 6 receptor antibody, should be considered."
Journal • Dermatology • Genito-urinary Cancer • Hepatology • Liver Failure • Oncology • Renal Cell Carcinoma • Solid Tumor • Steven-Johnson Syndrome • IL6R
|
|
Goshi Kitano; Hiroki Hirabayashi; Makoto Kawase; Ryo Nakagawa; Takahiro Kojima; Yushiro Takeuchi; Yutaka Fujiwara
|